Harvard Bioscience, Inc.【HBIO】 利益剰余金の推移

(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -208,350 +38.6%
4Q24 -158,010 +8.5%
3Q24 -158,028 +9.9%
2Q24 -153,226 +7.5%
1Q24 -150,299 +6.2%
4Q23 -145,605 +2.4%
3Q23 -143,787 +2.3%
2Q23 -142,548 +4.0%
1Q23 -141,568 +1.4%
4Q22 -142,190 +7.2%
3Q22 -140,524 +5.2%
2Q22 -137,119 +2.7%
1Q22 -139,554 +4.9%
4Q21 -132,674 +0.2%
3Q21 -133,635 +1.4%
2Q21 -133,465 +2.1%
1Q21 -133,055 +3.1%
4Q20 -132,386 +6.3%
3Q20 -131,771 +5.3%
2Q20 -130,673 +6.7%
1Q20 -129,092 +5.6%
4Q19 -124,576 +3.9%
3Q19 -125,125 +1.9%
2Q19 -122,506 0.0%
1Q19 -122,259 +1.0%
4Q18 -119,889 +2.5%
3Q18 -122,751 +4.1%
2Q18 -122,495 +4.2%
1Q18 -121,031 +3.3%
4Q17 -116,967 +0.8%
3Q17 -117,966 +2.8%
2Q17 -117,549 +4.0%
1Q17 -117,168 +4.3%
4Q16 -116,030 +3.9%
3Q16 -114,710 +21.3%
2Q16 -113,072 +20.6%
1Q16 -112,359 +19.4%
4Q15 -111,723 +20.5%
3Q15 -94,583 +2.1%
2Q15 -93,736 +0.5%
1Q15 -94,085 -0.2%
4Q15 -92,684 -2.5%
3Q14 -92,670 +18.3%
2Q15 -93,298 +20.6%
1Q15 -94,320 +22.2%
4Q14 -95,039 +23.0%
3Q13 -78,334 -0.2%
2Q13 -77,352 -1.2%
1Q14 -77,164 -2.4%
4Q13 -77,260 -3.0%
3Q12 -78,462 -2.4%
2Q12 -78,331 -2.6%
1Q12 -79,101 -
4Q12 -79,630 -
3Q11 -80,368 -
2Q11 -80,397 -